| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iran | 140 | 2024 | 708 | 15.140 |
Why?
|
| Quality-Adjusted Life Years | 59 | 2024 | 1683 | 5.060 |
Why?
|
| Accidents, Traffic | 8 | 2023 | 819 | 3.770 |
Why?
|
| Sodium Chloride, Dietary | 6 | 2021 | 281 | 3.470 |
Why?
|
| Automobile Driving | 6 | 2023 | 431 | 3.290 |
Why?
|
| Cost of Illness | 21 | 2023 | 1859 | 2.830 |
Why?
|
| Disabled Persons | 10 | 2024 | 1212 | 2.440 |
Why?
|
| Child Mortality | 7 | 2023 | 198 | 2.390 |
Why?
|
| Prevalence | 62 | 2024 | 15226 | 2.320 |
Why?
|
| Diabetes Mellitus | 22 | 2024 | 5751 | 1.990 |
Why?
|
| Hypertension | 19 | 2024 | 8480 | 1.940 |
Why?
|
| Incidence | 49 | 2024 | 20947 | 1.880 |
Why?
|
| Health Surveys | 18 | 2022 | 4037 | 1.850 |
Why?
|
| Life Expectancy | 14 | 2023 | 1184 | 1.820 |
Why?
|
| Infant Mortality | 5 | 2023 | 754 | 1.680 |
Why?
|
| Wounds and Injuries | 13 | 2021 | 2400 | 1.600 |
Why?
|
| Overweight | 8 | 2024 | 2371 | 1.560 |
Why?
|
| Hypercholesterolemia | 7 | 2023 | 1151 | 1.550 |
Why?
|
| Quality of Health Care | 19 | 2024 | 4371 | 1.530 |
Why?
|
| Middle East | 13 | 2024 | 219 | 1.490 |
Why?
|
| Myocardial Ischemia | 5 | 2024 | 2148 | 1.380 |
Why?
|
| Age Distribution | 22 | 2023 | 2902 | 1.370 |
Why?
|
| Risk Factors | 73 | 2024 | 72290 | 1.350 |
Why?
|
| Epidemiologic Research Design | 15 | 2014 | 367 | 1.340 |
Why?
|
| Male | 152 | 2024 | 350118 | 1.330 |
Why?
|
| Sex Distribution | 19 | 2022 | 2297 | 1.320 |
Why?
|
| Africa, Northern | 9 | 2024 | 82 | 1.310 |
Why?
|
| Humans | 246 | 2024 | 744343 | 1.280 |
Why?
|
| Endocarditis | 2 | 2022 | 350 | 1.240 |
Why?
|
| Obesity | 15 | 2024 | 12745 | 1.240 |
Why?
|
| Female | 154 | 2024 | 380194 | 1.210 |
Why?
|
| Developing Countries | 21 | 2024 | 2815 | 1.210 |
Why?
|
| Prediabetic State | 2 | 2023 | 499 | 1.210 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2023 | 816 | 1.190 |
Why?
|
| Feeding Behavior | 7 | 2023 | 3188 | 1.130 |
Why?
|
| Mortality | 16 | 2021 | 2864 | 1.080 |
Why?
|
| Exercise | 5 | 2023 | 5615 | 1.050 |
Why?
|
| Registries | 15 | 2021 | 8089 | 1.020 |
Why?
|
| Cardiovascular Diseases | 23 | 2024 | 15165 | 1.020 |
Why?
|
| Epidemiology | 4 | 2017 | 287 | 0.990 |
Why?
|
| Physicians, Family | 2 | 2017 | 345 | 0.980 |
Why?
|
| Adult | 103 | 2024 | 214055 | 0.970 |
Why?
|
| Rural Population | 8 | 2023 | 2210 | 0.950 |
Why?
|
| Cross-Sectional Studies | 36 | 2024 | 25043 | 0.940 |
Why?
|
| Hepatitis B | 2 | 2020 | 695 | 0.940 |
Why?
|
| Antihypertensive Agents | 6 | 2022 | 2046 | 0.930 |
Why?
|
| Bayes Theorem | 18 | 2024 | 2309 | 0.910 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2022 | 895 | 0.910 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3047 | 0.910 |
Why?
|
| Automobiles | 2 | 2021 | 116 | 0.910 |
Why?
|
| Socioeconomic Factors | 18 | 2023 | 7785 | 0.840 |
Why?
|
| Stomach Neoplasms | 6 | 2021 | 1333 | 0.840 |
Why?
|
| Head Protective Devices | 2 | 2021 | 114 | 0.820 |
Why?
|
| Aged | 75 | 2024 | 163280 | 0.810 |
Why?
|
| Tooth Loss | 1 | 2023 | 197 | 0.800 |
Why?
|
| Breast Neoplasms, Male | 1 | 2023 | 210 | 0.780 |
Why?
|
| Polypharmacy | 1 | 2024 | 294 | 0.780 |
Why?
|
| Income | 9 | 2022 | 1913 | 0.770 |
Why?
|
| Rural Health Services | 2 | 2017 | 379 | 0.770 |
Why?
|
| Cause of Death | 13 | 2021 | 3584 | 0.770 |
Why?
|
| Young Adult | 46 | 2024 | 56430 | 0.770 |
Why?
|
| Peptic Ulcer | 1 | 2022 | 223 | 0.760 |
Why?
|
| Hypertriglyceridemia | 1 | 2023 | 293 | 0.730 |
Why?
|
| Maternal Mortality | 2 | 2021 | 310 | 0.720 |
Why?
|
| Hepatitis C | 2 | 2022 | 1591 | 0.720 |
Why?
|
| Economics | 1 | 2020 | 146 | 0.710 |
Why?
|
| Middle Aged | 81 | 2024 | 213383 | 0.700 |
Why?
|
| Seat Belts | 1 | 2019 | 57 | 0.700 |
Why?
|
| Dental Caries | 1 | 2023 | 415 | 0.690 |
Why?
|
| Metals, Heavy | 1 | 2021 | 139 | 0.690 |
Why?
|
| Respiration Disorders | 1 | 2022 | 371 | 0.680 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 417 | 0.680 |
Why?
|
| Models, Statistical | 13 | 2021 | 5102 | 0.670 |
Why?
|
| Blood Pressure | 12 | 2022 | 8554 | 0.670 |
Why?
|
| Health Policy | 4 | 2023 | 2661 | 0.640 |
Why?
|
| Asthma | 6 | 2022 | 6011 | 0.640 |
Why?
|
| Particulate Matter | 5 | 2023 | 2530 | 0.640 |
Why?
|
| Pesticides | 1 | 2021 | 287 | 0.630 |
Why?
|
| Helicobacter Infections | 2 | 2021 | 386 | 0.630 |
Why?
|
| Infant, Newborn | 26 | 2023 | 25625 | 0.620 |
Why?
|
| Insulin Infusion Systems | 1 | 2019 | 212 | 0.620 |
Why?
|
| Health Status | 7 | 2024 | 4034 | 0.620 |
Why?
|
| Bibliometrics | 1 | 2021 | 339 | 0.610 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 382 | 0.610 |
Why?
|
| Body Mass Index | 15 | 2022 | 12720 | 0.600 |
Why?
|
| Goals | 3 | 2019 | 706 | 0.600 |
Why?
|
| Vital Statistics | 1 | 2017 | 34 | 0.580 |
Why?
|
| Transportation | 1 | 2018 | 214 | 0.580 |
Why?
|
| Cities | 2 | 2016 | 513 | 0.580 |
Why?
|
| Adolescent | 42 | 2023 | 85781 | 0.580 |
Why?
|
| Public Health | 6 | 2021 | 2603 | 0.560 |
Why?
|
| Stroke | 7 | 2022 | 9981 | 0.550 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 4253 | 0.540 |
Why?
|
| Population Surveillance | 4 | 2020 | 2616 | 0.510 |
Why?
|
| Data Collection | 3 | 2022 | 3341 | 0.510 |
Why?
|
| Government Programs | 1 | 2017 | 275 | 0.510 |
Why?
|
| Environmental Exposure | 5 | 2020 | 4234 | 0.500 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 523 | 0.500 |
Why?
|
| Commerce | 1 | 2020 | 592 | 0.500 |
Why?
|
| Midwifery | 1 | 2016 | 132 | 0.490 |
Why?
|
| Urologic Neoplasms | 1 | 2018 | 318 | 0.490 |
Why?
|
| Child, Preschool | 26 | 2024 | 41006 | 0.480 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1405 | 0.480 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 2020 | 0.480 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1073 | 0.480 |
Why?
|
| Infant | 24 | 2023 | 35136 | 0.480 |
Why?
|
| Leukemia | 1 | 2022 | 1511 | 0.480 |
Why?
|
| Environmental Illness | 1 | 2014 | 34 | 0.470 |
Why?
|
| Air Pollution | 4 | 2023 | 2286 | 0.470 |
Why?
|
| Disability Evaluation | 3 | 2019 | 1827 | 0.470 |
Why?
|
| Safety | 1 | 2018 | 1186 | 0.460 |
Why?
|
| Earthquakes | 1 | 2016 | 179 | 0.460 |
Why?
|
| Program Development | 1 | 2020 | 1316 | 0.460 |
Why?
|
| Feedback | 3 | 2023 | 795 | 0.460 |
Why?
|
| Social Class | 6 | 2022 | 1999 | 0.460 |
Why?
|
| Motivation | 1 | 2023 | 1971 | 0.450 |
Why?
|
| Diabetes, Gestational | 4 | 2023 | 1184 | 0.450 |
Why?
|
| Sodium | 1 | 2018 | 1623 | 0.450 |
Why?
|
| Neoplasms | 8 | 2022 | 21683 | 0.440 |
Why?
|
| Nutritional Status | 2 | 2021 | 1609 | 0.440 |
Why?
|
| Aged, 80 and over | 30 | 2021 | 57776 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 3923 | 0.430 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2208 | 0.430 |
Why?
|
| Research Design | 5 | 2018 | 5987 | 0.430 |
Why?
|
| National Health Programs | 1 | 2016 | 445 | 0.430 |
Why?
|
| Metabolome | 2 | 2019 | 895 | 0.420 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2245 | 0.420 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1797 | 0.420 |
Why?
|
| Multilevel Analysis | 5 | 2014 | 142 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 11725 | 0.420 |
Why?
|
| Awareness | 1 | 2016 | 640 | 0.400 |
Why?
|
| World Health Organization | 4 | 2023 | 1318 | 0.400 |
Why?
|
| Regression Analysis | 9 | 2021 | 6459 | 0.390 |
Why?
|
| Medical Records | 2 | 2014 | 1413 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 3336 | 0.380 |
Why?
|
| Child | 29 | 2024 | 77709 | 0.380 |
Why?
|
| History, 20th Century | 4 | 2020 | 2740 | 0.380 |
Why?
|
| Air Pollutants | 3 | 2019 | 2817 | 0.370 |
Why?
|
| History, 21st Century | 4 | 2020 | 1534 | 0.370 |
Why?
|
| Life Style | 4 | 2019 | 3835 | 0.370 |
Why?
|
| Primary Health Care | 5 | 2021 | 4558 | 0.370 |
Why?
|
| Multiple Sclerosis | 2 | 2023 | 3079 | 0.370 |
Why?
|
| Disasters | 1 | 2016 | 511 | 0.360 |
Why?
|
| Cesarean Section | 3 | 2023 | 1365 | 0.360 |
Why?
|
| Policy Making | 1 | 2014 | 554 | 0.350 |
Why?
|
| Vitamins | 1 | 2018 | 1622 | 0.350 |
Why?
|
| Cholesterol | 6 | 2022 | 2917 | 0.340 |
Why?
|
| Fraud | 2 | 2020 | 67 | 0.330 |
Why?
|
| Mental Disorders | 2 | 2022 | 6600 | 0.330 |
Why?
|
| Photography | 2 | 2022 | 520 | 0.330 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 1863 | 0.330 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.320 |
Why?
|
| Sarcopenia | 2 | 2024 | 368 | 0.320 |
Why?
|
| Amino Acids | 4 | 2023 | 1736 | 0.310 |
Why?
|
| Smoking | 6 | 2021 | 8987 | 0.310 |
Why?
|
| Smoking Cessation | 1 | 2020 | 2071 | 0.310 |
Why?
|
| Blood Glucose | 9 | 2023 | 6256 | 0.300 |
Why?
|
| Vision Disorders | 1 | 2014 | 1058 | 0.300 |
Why?
|
| Databases, Factual | 10 | 2021 | 7729 | 0.300 |
Why?
|
| Kidney | 1 | 2023 | 7186 | 0.300 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 5137 | 0.290 |
Why?
|
| Lipids | 1 | 2018 | 3305 | 0.290 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4262 | 0.290 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4838 | 0.290 |
Why?
|
| Sex Factors | 12 | 2021 | 10397 | 0.290 |
Why?
|
| Time Factors | 15 | 2021 | 40075 | 0.280 |
Why?
|
| Risk Assessment | 14 | 2023 | 23338 | 0.280 |
Why?
|
| Markov Chains | 5 | 2020 | 969 | 0.280 |
Why?
|
| Dyslipidemias | 1 | 2014 | 849 | 0.280 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5027 | 0.270 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 459 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1411 | 0.260 |
Why?
|
| Age Factors | 13 | 2021 | 18370 | 0.260 |
Why?
|
| Demography | 3 | 2021 | 1656 | 0.250 |
Why?
|
| Computer Simulation | 1 | 2018 | 6196 | 0.250 |
Why?
|
| Hospitals | 2 | 2021 | 3952 | 0.250 |
Why?
|
| Insulin | 1 | 2019 | 6580 | 0.250 |
Why?
|
| Pancreatic Neoplasms | 2 | 2021 | 5256 | 0.250 |
Why?
|
| Vitamin D | 1 | 2018 | 3223 | 0.240 |
Why?
|
| Health Promotion | 1 | 2016 | 2205 | 0.240 |
Why?
|
| Carnitine | 3 | 2022 | 246 | 0.240 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 3158 | 0.240 |
Why?
|
| Projection | 1 | 2023 | 18 | 0.240 |
Why?
|
| Oral Health | 2 | 2023 | 472 | 0.240 |
Why?
|
| Dentition, Permanent | 1 | 2023 | 21 | 0.230 |
Why?
|
| DMF Index | 1 | 2023 | 90 | 0.230 |
Why?
|
| Prescriptions | 2 | 2024 | 387 | 0.230 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 3086 | 0.230 |
Why?
|
| Geography | 3 | 2021 | 669 | 0.230 |
Why?
|
| Tunisia | 1 | 2022 | 33 | 0.230 |
Why?
|
| Alkaloids | 1 | 2024 | 190 | 0.220 |
Why?
|
| Osteoporosis | 2 | 2022 | 1580 | 0.220 |
Why?
|
| Lebanon | 1 | 2023 | 229 | 0.210 |
Why?
|
| Fetal Macrosomia | 4 | 2023 | 124 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2015 | 9146 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6773 | 0.210 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 1125 | 0.210 |
Why?
|
| Clinical Protocols | 4 | 2014 | 1462 | 0.200 |
Why?
|
| Data Mining | 2 | 2018 | 537 | 0.200 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 1414 | 0.200 |
Why?
|
| Tobacco, Smokeless | 1 | 2022 | 130 | 0.200 |
Why?
|
| Disease Outbreaks | 2 | 2014 | 1772 | 0.200 |
Why?
|
| Metabolomics | 5 | 2023 | 1484 | 0.200 |
Why?
|
| PubMed | 1 | 2021 | 123 | 0.190 |
Why?
|
| Insulin Resistance | 3 | 2022 | 3864 | 0.190 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2861 | 0.190 |
Why?
|
| Pregnancy in Diabetics | 1 | 2022 | 179 | 0.190 |
Why?
|
| Sampling Studies | 1 | 2022 | 623 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5686 | 0.190 |
Why?
|
| Premature Birth | 2 | 2023 | 1721 | 0.190 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 177 | 0.190 |
Why?
|
| Gallbladder | 1 | 2021 | 302 | 0.180 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2023 | 257 | 0.180 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 174 | 0.180 |
Why?
|
| Lip | 1 | 2021 | 195 | 0.180 |
Why?
|
| Aspirin | 3 | 2023 | 3282 | 0.180 |
Why?
|
| Health Transition | 2 | 2019 | 34 | 0.180 |
Why?
|
| Ozone | 1 | 2023 | 469 | 0.180 |
Why?
|
| Poverty Areas | 1 | 2021 | 275 | 0.170 |
Why?
|
| History of Medicine | 1 | 2019 | 35 | 0.170 |
Why?
|
| Urban Population | 3 | 2022 | 2021 | 0.170 |
Why?
|
| Sphingomyelins | 1 | 2019 | 105 | 0.170 |
Why?
|
| Systole | 1 | 2021 | 958 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 13102 | 0.160 |
Why?
|
| Mediterranean Region | 4 | 2019 | 47 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1479 | 0.160 |
Why?
|
| Telecommunications | 1 | 2018 | 80 | 0.160 |
Why?
|
| Thyroid Neoplasms | 2 | 2022 | 2282 | 0.160 |
Why?
|
| Australia | 1 | 2021 | 1170 | 0.160 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 231 | 0.160 |
Why?
|
| Diet | 3 | 2023 | 7939 | 0.160 |
Why?
|
| Hypothyroidism | 1 | 2023 | 658 | 0.160 |
Why?
|
| Fruit | 1 | 2023 | 1142 | 0.160 |
Why?
|
| Taxes | 1 | 2020 | 221 | 0.160 |
Why?
|
| Insurance, Health | 3 | 2020 | 2494 | 0.150 |
Why?
|
| Monte Carlo Method | 4 | 2020 | 1254 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 20822 | 0.150 |
Why?
|
| Policy | 1 | 2021 | 508 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 4258 | 0.150 |
Why?
|
| Peer Group | 1 | 2022 | 635 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2019 | 411 | 0.150 |
Why?
|
| Death Certificates | 1 | 2018 | 169 | 0.150 |
Why?
|
| Japan | 1 | 2021 | 1360 | 0.150 |
Why?
|
| Pandemics | 3 | 2022 | 8388 | 0.150 |
Why?
|
| Magnetite Nanoparticles | 1 | 2019 | 321 | 0.150 |
Why?
|
| Anthropometry | 1 | 2022 | 1350 | 0.150 |
Why?
|
| Nitrogen Dioxide | 1 | 2019 | 490 | 0.140 |
Why?
|
| State Health Plans | 1 | 2019 | 216 | 0.140 |
Why?
|
| Pregnancy | 10 | 2023 | 29144 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2023 | 1530 | 0.140 |
Why?
|
| Headache Disorders | 1 | 2019 | 130 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 582 | 0.140 |
Why?
|
| Health Services | 1 | 2022 | 758 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2019 | 331 | 0.140 |
Why?
|
| Visually Impaired Persons | 1 | 2017 | 81 | 0.140 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.140 |
Why?
|
| Reference Standards | 1 | 2020 | 1025 | 0.140 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 634 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3255 | 0.140 |
Why?
|
| Censuses | 1 | 2017 | 200 | 0.140 |
Why?
|
| Social Problems | 1 | 2016 | 112 | 0.140 |
Why?
|
| Forecasting | 2 | 2022 | 2951 | 0.130 |
Why?
|
| Bronchitis, Chronic | 1 | 2016 | 62 | 0.130 |
Why?
|
| Survival Rate | 3 | 2019 | 12788 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 2014 | 1170 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 579 | 0.130 |
Why?
|
| Homicide | 1 | 2018 | 287 | 0.130 |
Why?
|
| Neck Pain | 1 | 2017 | 180 | 0.130 |
Why?
|
| Achievement | 1 | 2017 | 291 | 0.130 |
Why?
|
| Developed Countries | 3 | 2023 | 437 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2022 | 1157 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.130 |
Why?
|
| Phenols | 1 | 2019 | 497 | 0.130 |
Why?
|
| Vision, Low | 1 | 2017 | 168 | 0.130 |
Why?
|
| Self Report | 3 | 2023 | 3558 | 0.130 |
Why?
|
| Fast Foods | 1 | 2016 | 197 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2018 | 780 | 0.120 |
Why?
|
| Family Practice | 1 | 2017 | 516 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2021 | 1359 | 0.120 |
Why?
|
| Publishing | 1 | 2021 | 833 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2356 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1660 | 0.120 |
Why?
|
| Opium | 1 | 2013 | 29 | 0.120 |
Why?
|
| Food Labeling | 1 | 2016 | 178 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1200 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 2232 | 0.120 |
Why?
|
| Dementia | 3 | 2019 | 2518 | 0.120 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 1686 | 0.120 |
Why?
|
| Dental Health Services | 1 | 2013 | 49 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2020 | 990 | 0.110 |
Why?
|
| China | 1 | 2019 | 2248 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 280 | 0.110 |
Why?
|
| Chromatography, Liquid | 3 | 2022 | 976 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 617 | 0.110 |
Why?
|
| Benzhydryl Compounds | 1 | 2019 | 845 | 0.110 |
Why?
|
| Decision Trees | 1 | 2014 | 506 | 0.110 |
Why?
|
| Prisons | 1 | 2014 | 161 | 0.110 |
Why?
|
| Diuretics | 1 | 2016 | 592 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2019 | 723 | 0.110 |
Why?
|
| Testicular Neoplasms | 1 | 2019 | 804 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 940 | 0.110 |
Why?
|
| Diarrhea | 2 | 2016 | 1348 | 0.110 |
Why?
|
| Pregnancy Outcome | 4 | 2023 | 2795 | 0.110 |
Why?
|
| Bone Density | 2 | 2022 | 3468 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 690 | 0.110 |
Why?
|
| HIV Infections | 5 | 2022 | 16718 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 563 | 0.110 |
Why?
|
| Urbanization | 1 | 2013 | 104 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 336 | 0.110 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2014 | 336 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 651 | 0.100 |
Why?
|
| Health Behavior | 2 | 2021 | 2636 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 961 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2020 | 10252 | 0.100 |
Why?
|
| Mouth Diseases | 1 | 2014 | 241 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 1518 | 0.100 |
Why?
|
| Prescription Drugs | 1 | 2018 | 595 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 867 | 0.100 |
Why?
|
| Narcotics | 1 | 2013 | 343 | 0.100 |
Why?
|
| Calcinosis | 1 | 2020 | 1499 | 0.100 |
Why?
|
| Vitamin E | 1 | 2015 | 869 | 0.100 |
Why?
|
| Firearms | 1 | 2018 | 598 | 0.100 |
Why?
|
| Logistic Models | 3 | 2022 | 13408 | 0.090 |
Why?
|
| Health Care Reform | 1 | 2020 | 1261 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1637 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2022 | 21746 | 0.090 |
Why?
|
| Prognosis | 3 | 2021 | 29063 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 3022 | 0.090 |
Why?
|
| Equipment Design | 1 | 2018 | 3582 | 0.090 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5319 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 1422 | 0.090 |
Why?
|
| Gout | 1 | 2017 | 573 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1061 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 1240 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2020 | 1922 | 0.090 |
Why?
|
| Research | 1 | 2018 | 1999 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 722 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 525 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 924 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2023 | 1150 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1344 | 0.090 |
Why?
|
| Psychiatry | 1 | 2022 | 1695 | 0.090 |
Why?
|
| Education, Medical | 1 | 2021 | 1721 | 0.090 |
Why?
|
| Aging | 3 | 2024 | 8664 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2017 | 1036 | 0.080 |
Why?
|
| DNA Damage | 1 | 2019 | 2432 | 0.080 |
Why?
|
| Comorbidity | 2 | 2023 | 10388 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 658 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2017 | 2488 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2017 | 956 | 0.080 |
Why?
|
| Organizational Objectives | 3 | 2014 | 438 | 0.080 |
Why?
|
| Preventive Health Services | 1 | 2013 | 575 | 0.080 |
Why?
|
| Suicide | 1 | 2018 | 1477 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.080 |
Why?
|
| Antioxidants | 1 | 2015 | 1663 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 1965 | 0.080 |
Why?
|
| Health Resources | 1 | 2013 | 911 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1471 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1420 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2015 | 880 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2011 | 488 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3278 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 975 | 0.070 |
Why?
|
| Universities | 2 | 2022 | 956 | 0.070 |
Why?
|
| Fasting | 3 | 2023 | 1593 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3309 | 0.070 |
Why?
|
| Poverty | 3 | 2022 | 2660 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2014 | 1253 | 0.060 |
Why?
|
| DNA | 1 | 2019 | 7301 | 0.060 |
Why?
|
| Morbidity | 2 | 2020 | 1769 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 63114 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4644 | 0.060 |
Why?
|
| Malaria | 1 | 2014 | 1239 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12026 | 0.060 |
Why?
|
| Risk | 2 | 2013 | 9687 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19905 | 0.060 |
Why?
|
| Phenotype | 2 | 2018 | 16365 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1912 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2303 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3297 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2158 | 0.050 |
Why?
|
| Models, Theoretical | 3 | 2021 | 3589 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 5034 | 0.050 |
Why?
|
| Inpatients | 1 | 2014 | 2518 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2538 | 0.050 |
Why?
|
| Africa | 2 | 2016 | 673 | 0.050 |
Why?
|
| Neglected Diseases | 1 | 2022 | 64 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 13881 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4567 | 0.050 |
Why?
|
| Enalapril | 1 | 2023 | 327 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2023 | 214 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 401 | 0.050 |
Why?
|
| Small-Area Analysis | 1 | 2021 | 55 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3712 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15540 | 0.050 |
Why?
|
| Space-Time Clustering | 1 | 2020 | 49 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3587 | 0.050 |
Why?
|
| Educational Status | 2 | 2020 | 2540 | 0.050 |
Why?
|
| NAD | 1 | 2024 | 593 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2022 | 724 | 0.040 |
Why?
|
| Persia | 1 | 2019 | 6 | 0.040 |
Why?
|
| England | 1 | 2021 | 522 | 0.040 |
Why?
|
| Heart Failure | 2 | 2014 | 10900 | 0.040 |
Why?
|
| Glycine | 1 | 2023 | 671 | 0.040 |
Why?
|
| Dielectric Spectroscopy | 1 | 2019 | 32 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 853 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 65 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12354 | 0.040 |
Why?
|
| Linear Models | 2 | 2019 | 5952 | 0.040 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 183 | 0.040 |
Why?
|
| History, Ancient | 1 | 2019 | 212 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 155 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2019 | 98 | 0.040 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 73 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 265 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 2018 | 81 | 0.040 |
Why?
|
| Alcohol Drinking | 2 | 2022 | 3966 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 141 | 0.040 |
Why?
|
| Vegetables | 1 | 2023 | 1182 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 845 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2282 | 0.040 |
Why?
|
| Djibouti | 1 | 2017 | 2 | 0.040 |
Why?
|
| Dimerization | 1 | 2019 | 893 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8037 | 0.040 |
Why?
|
| Somalia | 1 | 2017 | 77 | 0.040 |
Why?
|
| Depression | 1 | 2016 | 7766 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 850 | 0.040 |
Why?
|
| Electrodes | 1 | 2019 | 619 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1725 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 1184 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 26385 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 734 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9583 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11031 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1604 | 0.030 |
Why?
|
| Sanitation | 1 | 2015 | 93 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 437 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 1419 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5391 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1642 | 0.030 |
Why?
|
| Disabled Children | 1 | 2017 | 247 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 405 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2715 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.030 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.030 |
Why?
|
| Gastritis, Atrophic | 1 | 2013 | 31 | 0.030 |
Why?
|
| Western World | 1 | 2013 | 27 | 0.030 |
Why?
|
| Social Perception | 1 | 2017 | 425 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2292 | 0.030 |
Why?
|
| Cations | 1 | 2014 | 232 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2020 | 2453 | 0.030 |
Why?
|
| Thiazides | 1 | 2012 | 18 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 668 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 9959 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 313 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
| Warfarin | 1 | 2021 | 1496 | 0.030 |
Why?
|
| Weight Loss | 1 | 2023 | 2622 | 0.030 |
Why?
|
| Eye Diseases | 1 | 2017 | 669 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 651 | 0.020 |
Why?
|
| Prisoners | 1 | 2014 | 297 | 0.020 |
Why?
|
| Australasia | 1 | 2011 | 19 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 11727 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 1206 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1873 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 581 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1583 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 40561 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2022 | 53288 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2015 | 969 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2014 | 986 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4397 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 4931 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5456 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2541 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 523 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2012 | 749 | 0.020 |
Why?
|
| North America | 1 | 2011 | 1249 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4599 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2775 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1003 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1796 | 0.020 |
Why?
|
| Animals | 3 | 2024 | 168757 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2716 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 3339 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3340 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2015 | 6077 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6309 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 12804 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 7913 | 0.010 |
Why?
|
| Mice | 1 | 2024 | 81183 | 0.010 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.010 |
Why?
|